Editorially Independent Content, Supported with Advertising from Genentech and Carl Zeiss Meditec
Arshad M. Khanani, MD, Nancy Holekamp, MD
Show Description +
Nancy Holekamp, MD, offers her first impressions of the phase 2 BOULEVARD clinical trial. Arshad M. Khanani, MD, MA, discusses anti-VEGF treatment for diabetic retinopathy (DR).
Posted: 9/27/2018
Arshad M. Khanani, MD, Nancy Holekamp, MD
Nancy Holekamp, MD, offers her first impressions of the phase 2 BOULEVARD clinical trial. Arshad M. Khanani, MD, MA, discusses anti-VEGF treatment for diabetic retinopathy (DR).
Posted: 9/27/2018
Please log in to leave a comment.